CORBIN THERAPEUTICS AND PROTEOREX THERAPEUTICS ANNOUNCE A RESEARCH AND DEVELOPMENT COLLABORATION TO DISCOVER NOVEL UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

Toronto, ON, and Montreal, QC, May 19, 2017 – Proteorex Therapeutics Inc. (“Proteorex”), headquartered in JLABS @ Toronto, is excited to announce the start of their research and development collaboration with Montreal-based Corbin Therapeutics Inc. (“Corbin”). The collaboration will identify small molecules which efficiently inhibit an important and highly conserved ubiquitin protein. Proteorex will receive[…]